5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase, studied for its role in cellular methylation and NAD+ metabolism. It is used as a research tool in adipocyte and hepatocyte models in vitro, and NuVion stocks it in Australia as a 10mg vial.
- Small molecule inhibitor of nicotinamide N-methyltransferase (NNMT)
- Used to probe NNMT activity in cell based assays
- Applied in adipocyte and hepatocyte culture models
- Purity confirmed by RP-HPLC, identity by mass spectrometry
5-Amino-1MQ structure and research use
5-Amino-1MQ is 5-amino-1-methylquinolinium, a small quinolinium compound with no amino acid chain. It inhibits nicotinamide N-methyltransferase, the enzyme that methylates nicotinamide, which makes it a tool for studying how NNMT activity connects to the NAD+ pathway and cellular methylation. In the laboratory it is used in adipocyte and hepatocyte models.
5-Amino-1MQ research applications
- Recombinant NNMT enzyme assays quantifying 1-MNA or SAH formation by LC-MS for IC50 determination
- Selectivity profiling against related SAM-dependent methyltransferases such as PNMT, HNMT, COMT and DNMT1
- LC-MS/MS quantification of NAD+, NADH, nicotinamide, 1-MNA, SAM and SAH in NNMT-expressing cell lines
- Gene expression by qPCR (Fasn, Srebf1, Pparg) in differentiating 3T3-L1 adipocyte cultures
5-Amino-1MQ key facts
| Type | Small molecule, quinolinium NNMT inhibitor (not a peptide) |
|---|---|
| Also known as | 5-amino-1-methylquinolinium, 5-amino-1-methylquinoline, 5-Amino-1MQ, 5-A-1MQ |
| Vial size | 10mg, lyophilised |
| Purity | 99.41% by RP-HPLC, Janoshik Analytical |
| Analysed | 11 November 2025 |
Research profile: 5-Amino-1MQ: structure, mechanism and research use
Independent test: a sample of this product was analysed by Janoshik Analytical on 11 November 2025, purity 99.41% by RP-HPLC. The certificate is shown in the lab band on this page.






